Drozitumab (Anti-TNFRSF10B / TRAILR2 / CD262)
Product Specifications
CAS Number
912628-39-8
Synonyms
PRO 95780
Target
CD markers
Applications
Transmembrane Transporters
Additionnal Information
Drozitumab (Anti-TNFRSF10B / TRAILR2 / CD262) is a human monoclonal antibody targeted against the death receptor DR5 (TRAILR2, CD262, TNFRSF10B) with potent anti-tumor activity against rhabdomyosarcoma (RMS) xenografts. MW: 150 kD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC680669-100 1x 100 µL
P27 / KIP1 (SX53G8), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400253-100 1x 100 µL
Cytokeratin, LMW (AE-1), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470778-500 1x 500 µL
Cytokeratin 17 (KRT17/778), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details